Filtros : "Indexado no Medline" "European Journal of Pharmacology" Removidos: "Indexado no BIOSIS" "Machado, Hélio Rubens" "LOTUFO, PAULO ANDRADE" "Societá Editoriale Farmaceutica" Limpar

Filtros



Refine with date range


  • Source: European Journal of Pharmacology. Unidades: FCFRP, FORP, FMRP

    Subjects: HIPERTENSÃO, DOENÇAS VASCULARES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINEZ, Marcio L. L. et al. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, v. 591, n. 1-3, p. 224-230, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.06.096. Acesso em: 26 jun. 2024.
    • APA

      Martinez, M. L. L., Castro, M. M., Rizzi, E., Fernandes, K., Demacq, C., Bendhack, L. M., et al. (2008). Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, 591( 1-3), 224-230. doi:10.1016/j.ejphar.2008.06.096
    • NLM

      Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
    • Vancouver

      Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
  • Source: European Journal of Pharmacology. Unidades: FMRP, FCFRP, FORP

    Subjects: DIABETES MELLITUS, METALOPROTEINASES, DOENÇAS CARDIOVASCULARES, ESTRESSE OXIDATIVO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINEZ, Marcio L. L. et al. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, v. 599, n. 1-3, p. 110-116, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.10.007. Acesso em: 26 jun. 2024.
    • APA

      Martinez, M. L. L., Rizzi, E., Castro, M. M., Fernandes, K., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, 599( 1-3), 110-116. doi:10.1016/j.ejphar.2008.10.007
    • NLM

      Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
    • Vancouver

      Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: INFLAMAÇÃO, DOR, CITOQUÍMICA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CUNHA, Thiago M. et al. TNF-'alfa' and IL-1'beta' mediate inflammatory hypernociception in mice triggered by 'B IND.1' but not 'B IND.2' kinin receptor. European Journal of Pharmacology, v. 573, n. 1-3, p. 221-229, 2007Tradução . . Acesso em: 26 jun. 2024.
    • APA

      Cunha, T. M., Verri Júnior, W. A., Fukada, S. Y., Guerrero, A. T. G., Santodomingo-Garzón, T., Poole, S., et al. (2007). TNF-'alfa' and IL-1'beta' mediate inflammatory hypernociception in mice triggered by 'B IND.1' but not 'B IND.2' kinin receptor. European Journal of Pharmacology, 573( 1-3), 221-229.
    • NLM

      Cunha TM, Verri Júnior WA, Fukada SY, Guerrero ATG, Santodomingo-Garzón T, Poole S, Parada CA, Ferreira SH, Cunha F de Q. TNF-'alfa' and IL-1'beta' mediate inflammatory hypernociception in mice triggered by 'B IND.1' but not 'B IND.2' kinin receptor. European Journal of Pharmacology. 2007 ; 573( 1-3): 221-229.[citado 2024 jun. 26 ]
    • Vancouver

      Cunha TM, Verri Júnior WA, Fukada SY, Guerrero ATG, Santodomingo-Garzón T, Poole S, Parada CA, Ferreira SH, Cunha F de Q. TNF-'alfa' and IL-1'beta' mediate inflammatory hypernociception in mice triggered by 'B IND.1' but not 'B IND.2' kinin receptor. European Journal of Pharmacology. 2007 ; 573( 1-3): 221-229.[citado 2024 jun. 26 ]
  • Source: European Journal of Pharmacology. Unidades: FCFRP, FMRP

    Assunto: FARMACOGNOSIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VALÉRIO, Daniel Augusto Rodrigues et al. Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism. European Journal of Pharmacology, v. 562, n. 1-2. p. 155-163, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2007.01.029. Acesso em: 26 jun. 2024.
    • APA

      Valério, D. A. R., Cunha, T. M., Arakawa, N. S., Lemos, H. P., Costa, F. B. da, Parada, C. A., et al. (2007). Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism. European Journal of Pharmacology, 562( 1-2. p. 155-163). doi:10.1016/j.ejphar.2007.01.029
    • NLM

      Valério DAR, Cunha TM, Arakawa NS, Lemos HP, Costa FB da, Parada CA, Ferreira SH, Cunha F de Q, Verri Júnior WA. Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism [Internet]. European Journal of Pharmacology. 2007 ; 562( 1-2. p. 155-163):[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2007.01.029
    • Vancouver

      Valério DAR, Cunha TM, Arakawa NS, Lemos HP, Costa FB da, Parada CA, Ferreira SH, Cunha F de Q, Verri Júnior WA. Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism [Internet]. European Journal of Pharmacology. 2007 ; 562( 1-2. p. 155-163):[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2007.01.029
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      POMPERMAYER, Kenia et al. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. European Journal of Pharmacology, v. 556, n. 1-3, p. 215-222, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2006.10.065. Acesso em: 26 jun. 2024.
    • APA

      Pompermayer, K., Amaral, F. A., Fagundes, C. T., Vieira, A. T., Cunha, F. de Q., Teixeira, M. M., & Souza, D. G. (2007). Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. European Journal of Pharmacology, 556( 1-3), 215-222. doi:10.1016/j.ejphar.2006.10.065
    • NLM

      Pompermayer K, Amaral FA, Fagundes CT, Vieira AT, Cunha F de Q, Teixeira MM, Souza DG. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury [Internet]. European Journal of Pharmacology. 2007 ; 556( 1-3): 215-222.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.10.065
    • Vancouver

      Pompermayer K, Amaral FA, Fagundes CT, Vieira AT, Cunha F de Q, Teixeira MM, Souza DG. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury [Internet]. European Journal of Pharmacology. 2007 ; 556( 1-3): 215-222.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.10.065
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: ENDOTÉLIO VASCULAR, HIPERTENSÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA-MELO, Silvia Elaine et al. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. European Journal of Pharmacology, v. 542, p. 141-147, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2006.04.039. Acesso em: 26 jun. 2024.
    • APA

      Ferreira-Melo, S. E., Yugar-Toledo, J. C., Coelho, O. R., De Luca, I. M., Tanus-Santos, J. E., Hyslop, S., et al. (2006). Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. European Journal of Pharmacology, 542, 141-147. doi:10.1016/j.ejphar.2006.04.039
    • NLM

      Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, Irigoyen MC, Moreno Júnior H. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats [Internet]. European Journal of Pharmacology. 2006 ; 542 141-147.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.04.039
    • Vancouver

      Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, Irigoyen MC, Moreno Júnior H. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats [Internet]. European Journal of Pharmacology. 2006 ; 542 141-147.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.04.039
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: HEMODINÂMICA, FUMO, PNEUMOPATIAS, HIPERTENSÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAGANELLI, Maria Ondina et al. Hemodynamic effects of bupropion in anesthetized dogs. European Journal of Pharmacology, v. 530, p. 124-127, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.11.019. Acesso em: 26 jun. 2024.
    • APA

      Paganelli, M. O., Tanus-Santos, J. E., Sabha, M., Prado, J. F. do, Chaud, M. V., Martins, L. C., & Moreno Júnior, H. (2006). Hemodynamic effects of bupropion in anesthetized dogs. European Journal of Pharmacology, 530, 124-127. doi:10.1016/j.ejphar.2005.11.019
    • NLM

      Paganelli MO, Tanus-Santos JE, Sabha M, Prado JF do, Chaud MV, Martins LC, Moreno Júnior H. Hemodynamic effects of bupropion in anesthetized dogs [Internet]. European Journal of Pharmacology. 2006 ; 530 124-127.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.11.019
    • Vancouver

      Paganelli MO, Tanus-Santos JE, Sabha M, Prado JF do, Chaud MV, Martins LC, Moreno Júnior H. Hemodynamic effects of bupropion in anesthetized dogs [Internet]. European Journal of Pharmacology. 2006 ; 530 124-127.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.11.019
  • Source: European Journal of Pharmacology. Unidades: FCFRP, FMRP

    Subjects: ERROS INATOS DO METABOLISMO DOS AMINOÁCIDOS, ARTÉRIAS CARÓTIDAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ANDRADE, Claudia Roberta de et al. ''alfa' IND.1D'-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. European Journal of Pharmacology, v. 543, p. 83-91, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2006.06.003. Acesso em: 26 jun. 2024.
    • APA

      Andrade, C. R. de, Fukada, S. Y., Olivon, V. C., Godoy, M. A. F. de, Haddad, R., Eberlin, M. N., et al. (2006). ''alfa' IND.1D'-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. European Journal of Pharmacology, 543, 83-91. doi:10.1016/j.ejphar.2006.06.003
    • NLM

      Andrade CR de, Fukada SY, Olivon VC, Godoy MAF de, Haddad R, Eberlin MN, Cunha F de Q, Souza HP, Laurindo FRM, Oliveira AM de. ''alfa' IND.1D'-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia [Internet]. European Journal of Pharmacology. 2006 ; 543 83-91.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.06.003
    • Vancouver

      Andrade CR de, Fukada SY, Olivon VC, Godoy MAF de, Haddad R, Eberlin MN, Cunha F de Q, Souza HP, Laurindo FRM, Oliveira AM de. ''alfa' IND.1D'-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia [Internet]. European Journal of Pharmacology. 2006 ; 543 83-91.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.06.003
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: FARMACOLOGIA, DOR, ARTRITE, ARTICULAÇÃO DO JOELHO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VALE, Mariana L. et al. Anti-nociceptive effect of thalidomide on zymosan-induced experimental articular incapacitation. European Journal of Pharmacology, v. 536, p. 309-317, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2006.02.051. Acesso em: 26 jun. 2024.
    • APA

      Vale, M. L., Cunha, F. de Q., Brito, G. A. C., Benevides, V. M., Ferreira, S. H., Poole, S., & Ribeiro, R. A. (2006). Anti-nociceptive effect of thalidomide on zymosan-induced experimental articular incapacitation. European Journal of Pharmacology, 536, 309-317. doi:10.1016/j.ejphar.2006.02.051
    • NLM

      Vale ML, Cunha F de Q, Brito GAC, Benevides VM, Ferreira SH, Poole S, Ribeiro RA. Anti-nociceptive effect of thalidomide on zymosan-induced experimental articular incapacitation [Internet]. European Journal of Pharmacology. 2006 ; 536 309-317.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.02.051
    • Vancouver

      Vale ML, Cunha F de Q, Brito GAC, Benevides VM, Ferreira SH, Poole S, Ribeiro RA. Anti-nociceptive effect of thalidomide on zymosan-induced experimental articular incapacitation [Internet]. European Journal of Pharmacology. 2006 ; 536 309-317.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.02.051
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: ANGIOTENSINA II, EDEMA ANGIONEURÓTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARVALHO, Raquel F. et al. Angiotensin II potentiates inflammatory edema in rats: role of mast cell degranulation. European Journal of Pharmacology, v. 540, p. 175-182, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2006.04.014. Acesso em: 26 jun. 2024.
    • APA

      Carvalho, R. F., Ribeiro, R. A., Falcão, R. A., Lima, R. C., Leitão, R. F. C., Alcântara, C., et al. (2006). Angiotensin II potentiates inflammatory edema in rats: role of mast cell degranulation. European Journal of Pharmacology, 540, 175-182. doi:10.1016/j.ejphar.2006.04.014
    • NLM

      Carvalho RF, Ribeiro RA, Falcão RA, Lima RC, Leitão RFC, Alcântara C, Souza MHLP, Cunha F de Q, Brito GAC. Angiotensin II potentiates inflammatory edema in rats: role of mast cell degranulation [Internet]. European Journal of Pharmacology. 2006 ; 540 175-182.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.04.014
    • Vancouver

      Carvalho RF, Ribeiro RA, Falcão RA, Lima RC, Leitão RFC, Alcântara C, Souza MHLP, Cunha F de Q, Brito GAC. Angiotensin II potentiates inflammatory edema in rats: role of mast cell degranulation [Internet]. European Journal of Pharmacology. 2006 ; 540 175-182.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2006.04.014
  • Source: European Journal of Pharmacology. Unidade: FCFRP

    Subjects: METABOLISMO, BIOENERGÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ANDREU, Gilberto Pardo et al. Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by 'Fe POT 2+'-citrate. European Journal of Pharmacology, v. 513, p. 47-55, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.03.007. Acesso em: 26 jun. 2024.
    • APA

      Andreu, G. P., Delgado, R., Velho, J. A., Curti, C., & Vercesi, A. (2005). Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by 'Fe POT 2+'-citrate. European Journal of Pharmacology, 513, 47-55. doi:10.1016/j.ejphar.2005.03.007
    • NLM

      Andreu GP, Delgado R, Velho JA, Curti C, Vercesi A. Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by 'Fe POT 2+'-citrate [Internet]. European Journal of Pharmacology. 2005 ; 513 47-55.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.03.007
    • Vancouver

      Andreu GP, Delgado R, Velho JA, Curti C, Vercesi A. Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by 'Fe POT 2+'-citrate [Internet]. European Journal of Pharmacology. 2005 ; 513 47-55.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.03.007
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA-SILVA, Allethea R. et al. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. European Journal of Pharmacology, v. 524, p. 126-131, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.09.022. Acesso em: 26 jun. 2024.
    • APA

      Souza-Silva, A. R., Dias Junior, C. A., Uzuelli, J. A., Moreno Junior, H., Evora, P. R., & Tanus-Santos, J. E. (2005). Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. European Journal of Pharmacology, 524, 126-131. doi:10.1016/j.ejphar.2005.09.022
    • NLM

      Souza-Silva AR, Dias Junior CA, Uzuelli JA, Moreno Junior H, Evora PR, Tanus-Santos JE. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension [Internet]. European Journal of Pharmacology. 2005 ; 524 126-131.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.09.022
    • Vancouver

      Souza-Silva AR, Dias Junior CA, Uzuelli JA, Moreno Junior H, Evora PR, Tanus-Santos JE. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension [Internet]. European Journal of Pharmacology. 2005 ; 524 126-131.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.09.022
  • Source: European Journal of Pharmacology. Unidade: ICB

    Assunto: IMUNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LANDGRAF, Richardt G. e RUSSO, Momtchilo e JANCAR, Sônia. Acute inhibition of inducible nitric oxide synthase but not its absence suppresses asthma-like responses. European Journal of Pharmacology, v. 518, n. 2-3, p. 212-220, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.04.047. Acesso em: 26 jun. 2024.
    • APA

      Landgraf, R. G., Russo, M., & Jancar, S. (2005). Acute inhibition of inducible nitric oxide synthase but not its absence suppresses asthma-like responses. European Journal of Pharmacology, 518( 2-3), 212-220. doi:10.1016/j.ejphar.2005.04.047
    • NLM

      Landgraf RG, Russo M, Jancar S. Acute inhibition of inducible nitric oxide synthase but not its absence suppresses asthma-like responses [Internet]. European Journal of Pharmacology. 2005 ; 518( 2-3): 212-220.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.04.047
    • Vancouver

      Landgraf RG, Russo M, Jancar S. Acute inhibition of inducible nitric oxide synthase but not its absence suppresses asthma-like responses [Internet]. European Journal of Pharmacology. 2005 ; 518( 2-3): 212-220.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.04.047
  • Source: European Journal of Pharmacology. Unidade: FCFRP

    Subjects: FARMACOLOGIA, CARDIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MOLIN, Josiane C. e SGUILLA, Fabiana S. e BENDHACK, Lusiane Maria. Decreased contraction to phenylephrine by ouabain in 2K-1C rat aorta is modulated by the endothelium. European Journal of Pharmacology, v. 522, p. 94-99, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.08.034. Acesso em: 26 jun. 2024.
    • APA

      Molin, J. C., Sguilla, F. S., & Bendhack, L. M. (2005). Decreased contraction to phenylephrine by ouabain in 2K-1C rat aorta is modulated by the endothelium. European Journal of Pharmacology, 522, 94-99. doi:10.1016/j.ejphar.2005.08.034
    • NLM

      Molin JC, Sguilla FS, Bendhack LM. Decreased contraction to phenylephrine by ouabain in 2K-1C rat aorta is modulated by the endothelium [Internet]. European Journal of Pharmacology. 2005 ; 522 94-99.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.08.034
    • Vancouver

      Molin JC, Sguilla FS, Bendhack LM. Decreased contraction to phenylephrine by ouabain in 2K-1C rat aorta is modulated by the endothelium [Internet]. European Journal of Pharmacology. 2005 ; 522 94-99.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.08.034
  • Source: European Journal of Pharmacology. Unidades: EEFE, FM

    Subjects: SISTEMA RENINA-ANGIOTENSINA (ENZIMOLOGIA), MIOCARDIOPATIA HIPERTRÓFICA (ENZIMOLOGIA)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLIVEIRA, E. M. e KRIEGER, José E. Chronic ß-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. European Journal of Pharmacology, v. 520, p. 135-141, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.07.026. Acesso em: 26 jun. 2024.
    • APA

      Oliveira, E. M., & Krieger, J. E. (2005). Chronic ß-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. European Journal of Pharmacology, 520, 135-141. doi:10.1016/j.ejphar.2005.07.026
    • NLM

      Oliveira EM, Krieger JE. Chronic ß-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin [Internet]. European Journal of Pharmacology. 2005 ; 520 135-141.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.07.026
    • Vancouver

      Oliveira EM, Krieger JE. Chronic ß-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin [Internet]. European Journal of Pharmacology. 2005 ; 520 135-141.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.07.026
  • Source: European Journal of Pharmacology. Unidade: FCFRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TEIXEIRA, Cleber E. et al. Effects of 'beta'-adrenoceptor antagonists in the neural nitric oxide release induced by electrical field stimulation and sodium channel activators in the rabbit corpus cavernosum. European Journal of Pharmacology, v. 519, p. 146-153, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.07.011. Acesso em: 26 jun. 2024.
    • APA

      Teixeira, C. E., Baracat, J. S., Arantes, E. C., De Nucci, G., & Antunes, E. (2005). Effects of 'beta'-adrenoceptor antagonists in the neural nitric oxide release induced by electrical field stimulation and sodium channel activators in the rabbit corpus cavernosum. European Journal of Pharmacology, 519, 146-153. doi:10.1016/j.ejphar.2005.07.011
    • NLM

      Teixeira CE, Baracat JS, Arantes EC, De Nucci G, Antunes E. Effects of 'beta'-adrenoceptor antagonists in the neural nitric oxide release induced by electrical field stimulation and sodium channel activators in the rabbit corpus cavernosum [Internet]. European Journal of Pharmacology. 2005 ; 519 146-153.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.07.011
    • Vancouver

      Teixeira CE, Baracat JS, Arantes EC, De Nucci G, Antunes E. Effects of 'beta'-adrenoceptor antagonists in the neural nitric oxide release induced by electrical field stimulation and sodium channel activators in the rabbit corpus cavernosum [Internet]. European Journal of Pharmacology. 2005 ; 519 146-153.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2005.07.011
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BOMBINI, Gustavo et al. Tumour necrosis factor-'alfa' mediates neutrophil migration to the knee synovial cavity during immune inflammation. European Journal of Pharmacology, v. 496, p. 197-204, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2004.06.003. Acesso em: 26 jun. 2024.
    • APA

      Bombini, G., Canetti, C., Rocha, F. A. C. da, & Cunha, F. de Q. (2004). Tumour necrosis factor-'alfa' mediates neutrophil migration to the knee synovial cavity during immune inflammation. European Journal of Pharmacology, 496, 197-204. doi:10.1016/j.ejphar.2004.06.003
    • NLM

      Bombini G, Canetti C, Rocha FAC da, Cunha F de Q. Tumour necrosis factor-'alfa' mediates neutrophil migration to the knee synovial cavity during immune inflammation [Internet]. European Journal of Pharmacology. 2004 ; 496 197-204.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2004.06.003
    • Vancouver

      Bombini G, Canetti C, Rocha FAC da, Cunha F de Q. Tumour necrosis factor-'alfa' mediates neutrophil migration to the knee synovial cavity during immune inflammation [Internet]. European Journal of Pharmacology. 2004 ; 496 197-204.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2004.06.003
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Francisco Airton Castro da et al. Blockade of leukotrine 'B IND.4' prevents articular incapacitation in rat zymosan-induced arthritis. European Journal of Pharmacology, v. 497, p. 81-86, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2004.06.025. Acesso em: 26 jun. 2024.
    • APA

      Rocha, F. A. C. da, Teixeira, M. M., Rocha, J. C. da S., Girão, V. C. C., Bezerra, M. M., Ribeiro, R. de A., & Cunha, F. de Q. (2004). Blockade of leukotrine 'B IND.4' prevents articular incapacitation in rat zymosan-induced arthritis. European Journal of Pharmacology, 497, 81-86. doi:10.1016/j.ejphar.2004.06.025
    • NLM

      Rocha FAC da, Teixeira MM, Rocha JC da S, Girão VCC, Bezerra MM, Ribeiro R de A, Cunha F de Q. Blockade of leukotrine 'B IND.4' prevents articular incapacitation in rat zymosan-induced arthritis [Internet]. European Journal of Pharmacology. 2004 ; 497 81-86.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2004.06.025
    • Vancouver

      Rocha FAC da, Teixeira MM, Rocha JC da S, Girão VCC, Bezerra MM, Ribeiro R de A, Cunha F de Q. Blockade of leukotrine 'B IND.4' prevents articular incapacitation in rat zymosan-induced arthritis [Internet]. European Journal of Pharmacology. 2004 ; 497 81-86.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2004.06.025
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CUNHA, Joice M. da et al. Endothelins induce E'T IND.B' receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C. European Journal of Pharmacology, v. 501, p. 87-94, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2004.08.004. Acesso em: 26 jun. 2024.
    • APA

      Cunha, J. M. da, Rae, G. A., Ferreira, S. H., & Cunha, F. de Q. (2004). Endothelins induce E'T IND.B' receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C. European Journal of Pharmacology, 501, 87-94. doi:10.1016/j.ejphar.2004.08.004
    • NLM

      Cunha JM da, Rae GA, Ferreira SH, Cunha F de Q. Endothelins induce E'T IND.B' receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C [Internet]. European Journal of Pharmacology. 2004 ; 501 87-94.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2004.08.004
    • Vancouver

      Cunha JM da, Rae GA, Ferreira SH, Cunha F de Q. Endothelins induce E'T IND.B' receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C [Internet]. European Journal of Pharmacology. 2004 ; 501 87-94.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2004.08.004
  • Source: European Journal of Pharmacology. Unidade: FCFRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TIRAPELLI, Carlos Renato et al. Analysis of the machanisms underlying the vasorelaxant action of kaurenoic and in the isolated rat aorta. European Journal of Pharmacology, v. 492, p. 233-241, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2004.04.003. Acesso em: 26 jun. 2024.
    • APA

      Tirapelli, C. R., Ambrósio, S. R., Costa, F. B. da, Coutinho, S. B., Oliveira, D. C. R. de, & Oliveira, A. M. de. (2004). Analysis of the machanisms underlying the vasorelaxant action of kaurenoic and in the isolated rat aorta. European Journal of Pharmacology, 492, 233-241. doi:10.1016/j.ejphar.2004.04.003
    • NLM

      Tirapelli CR, Ambrósio SR, Costa FB da, Coutinho SB, Oliveira DCR de, Oliveira AM de. Analysis of the machanisms underlying the vasorelaxant action of kaurenoic and in the isolated rat aorta [Internet]. European Journal of Pharmacology. 2004 ; 492 233-241.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2004.04.003
    • Vancouver

      Tirapelli CR, Ambrósio SR, Costa FB da, Coutinho SB, Oliveira DCR de, Oliveira AM de. Analysis of the machanisms underlying the vasorelaxant action of kaurenoic and in the isolated rat aorta [Internet]. European Journal of Pharmacology. 2004 ; 492 233-241.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.ejphar.2004.04.003

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024